
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell t... Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricor's proprietary StealthX¿ exosome platform has potential for a broad range of new therapeutic applications in the field of vaccinology as well as targeted oligonucleotide, protein and small molecule therapeutics to treat or prevent a variety of diseases. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.33 | -21.2101910828 | 15.7 | 16.17 | 12.05 | 1928125 | 14.10427205 | CS |
4 | -2.67 | -17.7526595745 | 15.04 | 16.465 | 12.05 | 1350202 | 14.62584859 | CS |
12 | -2.48 | -16.7003367003 | 14.85 | 16.465 | 12.05 | 1108938 | 14.21731629 | CS |
26 | 8.03 | 185.023041475 | 4.34 | 23.4 | 3.98 | 2305754 | 14.50803444 | CS |
52 | 7.72 | 166.021505376 | 4.65 | 23.4 | 3.52 | 1321713 | 13.22878824 | CS |
156 | 7.83 | 172.466960352 | 4.54 | 23.4 | 2.68 | 546185 | 11.48286648 | CS |
260 | 11.22 | 975.652173913 | 1.15 | 23.4 | 0.88 | 946597 | 8.04095394 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions